<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Oral Tofacitinib Produces Hair Regrowth in Children With Alopecia Areata

Default sub title

minute read

by Medscape | February 14, 2022
placeholder

Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) in a small study conducted at the University of Colorado and published in Pediatric Dermatology.

Topics: Press Coverage